Results 81 to 90 of about 9,833 (206)

Myocardial-salvaging Effects of a Novel Polyherbal Combination with Dipeptidyl Peptidase-4 Inhibitory Activity

open access: yesNigerian Postgraduate Medical Journal
Background: Some of the medicinal plants possess dipeptidyl peptidase-4 (DPP-4) inhibitory properties and could overcome the limitations of synthetic DPP-4 inhibitors.
Devkumar Durgaprasad Tiwari   +5 more
doaj   +1 more source

EDGE study in Russian Federation: efficacy and safety of vildagliptine in comparison with other oral antidiabetic agents in patients with type 2 diabetes mellitus

open access: yesСахарный диабет, 2013
According to international consensus, metformin is acknowledged as a first-line therapeutic agent for type 2 diabetes mellitus (T2DM). However, in most cases this treatment eventually requires intensification by supplementation with other hypoglycemic ...
Gagik Radikovich Galstyan
doaj   +1 more source

PDB24 Prevalence and economic burden of diabetes in africa [PDF]

open access: yes, 2014
Antidiabetic activities of Phaleria macrocarpa fruits and Annona muricata leaves through α-glucosidase inhibition have been reported. Each extract of the two medicinal plants showed weak α-glucosidase inhibitory activities.
Darusman, Latifah Kosim   +3 more
core   +3 more sources

Individualizing treatment targets for elderly patients with type 2 diabetes: factors influencing clinical decision making in the 24-week, randomized INTERVAL study. [PDF]

open access: yes, 2017
ArticleThis is the final version of the article. Available from Impact Journals via the DOI in this record.We tested the feasibility of setting individualized glycemic goals and factors influencing targets set in a clinical trial in elderly patients with
Abhijit, A, Paldanius, PM, Strain, WD
core   +1 more source

Managing diabetic patients with moderate or severe renal impairment using DPP-4 inhibitors: focus on vildagliptin

open access: yesDiabetes, Metabolic Syndrome and Obesity, 2013
Eleonora Russo, Giuseppe Penno, Stefano Del Prato Department of Clinical and Experimental Medicine, Section of Diabetes and Metabolic Disease, Azienda Ospedaliero Universitaria di Pisa, and University of Pisa, Pisa, Italy Background: Dipeptidyl peptidase-
Russo E, Penno G, Del Prato S
doaj  

Analgesic and anti-inflammatory effectiveness of sitagliptin and vildagliptin in mice [PDF]

open access: yes, 2021
Cayasso, Mayella   +6 more
core   +1 more source

IRS proteins and diabetic complications [PDF]

open access: yes, 2016
IRS proteins are cellular adaptor molecules that mediate many of the key metabolic actions of insulin. When tyrosine is phosphorylated by the activated insulin receptor, IRS proteins recruit downstream effectors, such as phosphoinositide 3-kinase and ...
Brazil, Derek P.   +2 more
core   +1 more source

Mild acute pancreatitis with vildagliptin use

open access: yesIndian Journal of Endocrinology and Metabolism, 2012
Vildagliptin has not been associated with the development of acute pancreatitis in postmarketing reports except one case report from Sydney, Australia.
Ravikant Saraogi   +2 more
doaj   +1 more source

Cardiovascular outcomes of vildagliptin in patients with type 2 diabetes mellitus after acute coronary syndrome or acute ischemic stroke

open access: yesJournal of Diabetes Investigation, 2020
Aims/Introduction The cardiovascular (CV) outcomes of vildagliptin – a dipeptidyl peptidase‐4 inhibitor – in patients with type 2 diabetes mellitus after acute coronary syndrome or acute ischemic stroke are unclear. Materials and Methods We analyzed data
Dong‐Yi Chen   +10 more
doaj   +1 more source

Effect of a patient engagement tool on positive airway pressure adherence: analysis of a German healthcare provider database [PDF]

open access: yes, 2018
Objective/background: This study investigated the addition of a real-time feedback patient engagement tool on positive airway pressure (PAP) adherence when added to a proactive telemedicine strategy.
Arzt, Michael   +6 more
core   +1 more source

Home - About - Disclaimer - Privacy